Senior Scientist Dr. Raj Krishnaswamy to Discuss Environmental Impact
and Industry Challenges of Bioplastics at Leading Plastics Conference
BOSTON--(BUSINESS WIRE)--
ANTEC Boston—Metabolix,
a leading industrial biotechnology company focused on developing clean,
sustainable solutions for plastics, chemicals and energy, today
announced that Senior Scientist Dr. Raj Krishnaswamy will present at ANTEC
2011's Fundamentals and Fellows Forum. Dr. Krishnaswamy's
presentation, "Opportunities and Challenges in Biobased and
Biodegradable Plastics," will explore the history of bioplastics,
discuss the environmental impact of these materials and examine the
current landscape of commercially available bioplastics. The
presentation will help attendees learn more about the major technical
challenges that bioplastics must overcome to sustain the current
high-growth rate in their production and utilization.
What:
|
|
|
"Opportunities and Challenges in Biobased and Biodegradable Plastics"
|
|
|
|
|
Who:
|
|
|
Dr. Raj Krishnaswamy, senior scientist, Metabolix, Inc.
|
|
|
|
|
When:
|
|
|
Monday, May 2, 2011 at 9:00 a.m. ET
|
|
|
|
|
Where:
|
|
|
ANTEC 2011
|
|
|
|
Hynes Convention Center
|
|
|
|
900 Boylston St., Boston, Massachusetts
|
|
|
|
|
About the Speaker
Dr. Raj Krishnaswamy is a senior scientist at Metabolix, Inc. where he
leads the development of a family of biobased and biodegradable polymers
for film and blow-molding applications. Prior to joining Metabolix in
2006, Dr. Krishnaswamy spent nine years in the polymer science group at
Chevron Phillips Chemical Company.
Earlier this year, Dr. Krishnaswamy received the Society of Plastics
Engineers (SPE) Research and Technology award. He currently serves on
the editorial boards of the Journal of Plastic Film and Sheeting
and the Encyclopedia of Polymer Science and Technology.
Additionally, he serves on the Engineering Properties and Structure
Division (EPSDIV) and bioplastics boards of SPE, as well as the
materials science board of the American Institute of Chemical Engineers
(AIChE). To date, Dr. Krishnaswamy has co-authored more than 40
peer-reviewed papers, and has been an invited speaker at many
conferences and universities worldwide.
About Metabolix
Founded in 1992, Metabolix, Inc. is an innovation-driven bioscience
company focused on providing sustainable solutions for the world's needs
for plastics, chemicals and energy. The Company is taking a systems
approach, from gene to end product, integrating sophisticated
biotechnology with advanced industrial practice. Metabolix is now
developing and commercializing Mirel™, a family of high-performance
bioplastics which are biobased and biodegradable alternatives to many
petroleum-based plastics, through Telles, a joint venture between
Metabolix and Archer Daniels Midland Company. Metabolix is also
developing biosourced industrial chemicals and a proprietary platform
technology for co-producing plastics, chemicals and energy, from crops
such as switchgrass, oilseeds and sugarcane.
For more information, please visit www.metabolix.com.
(MBLX-G)
Media:
Schwartz Communications
Keith Giannini or Jen Barlow,
781-684-0770
metabolix@schwartzcomm.com
or
Investors:
ICR
James
Palczynski, 203-682-8229
james.palczynski@icrinc.com
Source: Metabolix, Inc.
News Provided by Acquire Media